tirzepatide semaglutide combo Ozempic® (semaglutide) and Mounjaro™ (tirzepatide), a major breakthrough for the treatment of obesity Concerns Surrounding Compounded GLP-1s Mount

Under certain circumstances, clinicians may prescribe certain stimulant drugs for off-label purposes, including to help lose weight or address binge eating concerns, as these medications may make you less hungry or cause your body to burn calories faster than usual

Consistent Quality: Subject to strict manufacturing and quality control standards

The most frequently reported AEs are gastrointestinal in nature, including nausea, vomiting, diarrhea and constipation, reflective of the effects of GLP-1 agonists on the gastrointestinal system

Discontinuing Ozempic due to intolerable side effects does not mean abandoning effective diabetes managementnumerous evidence-based alternatives can achieve excellent glycaemic control whilst maintaining tolerability